Coloplast A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CLPBY research report →
Companywww.coloplast.com
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
- CEO
- Lars Soren Rasmussen
- IPO
- 2014
- Employees
- 16,741
- HQ
- Humlebæk, DK
Price Chart
Valuation
- Market Cap
- $14.54B
- P/E
- 44.08
- P/S
- 3.31
- P/B
- 7.23
- EV/EBITDA
- 10.22
- Div Yield
- 5.58%
Profitability
- Gross Margin
- 58.60%
- Op Margin
- 26.47%
- Net Margin
- 7.51%
- ROE
- 14.23%
- ROIC
- 10.58%
Growth & Income
- Revenue
- $26.25B · -2.87%
- Net Income
- $3.42B · -32.21%
- EPS
- $1.52 · -32.37%
- Op Income
- $7.14B
- FCF YoY
- 214.31%
Performance & Tape
- 52W High
- $10.03
- 52W Low
- $6.10
- 50D MA
- $6.59
- 200D MA
- $8.28
- Beta
- 0.50
- Avg Volume
- 700.41K
Get TickerSpark's AI analysis on CLPBY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CLPBY Coverage
We haven't published any research on CLPBY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CLPBY Report →